Prospect Capital Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-22,500
Closed -$1.35M 30
2021
Q4
$1.35M Sell
22,500
-5,000
-18% -$311K 0.53% 26
2021
Q3
$1.8M Sell
27,500
-7,500
-21% -$487K 0.59% 30
2021
Q2
$2.21M Sell
35,000
-5,925
-14% -$340K 0.82% 27
2021
Q1
$2M Sell
40,925
-56,425
-58% -$2.71M 0.88% 25
2020
Q4
$4.02M Sell
97,350
-4,850
-5% -$222K 1.66% 19
2020
Q3
$4.69M Buy
102,200
+100
+0.1% +$4.64K 2.47% 13
2020
Q2
$4.47M Sell
102,100
-10,150
-9% -$456K 2.71% 12
2020
Q1
$4.45M Sell
112,250
-31,000
-22% -$1.39M 3.02% 13
2019
Q4
$6.73M Sell
143,250
-139,050
-49% -$5.39M 4.13% 11
2019
Q3
$9.95M Buy
282,300
+52,200
+23% +$1.81M 5.04% 8
2019
Q2
$8.97M Buy
230,100
+24,000
+12% +$968K 3.82% 13
2019
Q1
$9.12M Buy
206,100
+1,500
+0.7% +$57.1K 4.69% 9
2018
Q4
$7.14M Buy
+204,600
New +$6.48M 4.24% 12

Other funds holding KIDS

Prospect Capital Advisors's KIDS Position: Q1 2022 in Review

Prospect Capital Advisors sold out of OrthoPediatrics (KIDS) in Q1 2022, closing a stake of 22,500 shares — an estimated $1.35M sold.

Prospect Capital Advisors first reported a position in KIDS in Q4 2018 and held it in 13 quarters. The position peaked at $9.95M in Q3 2019. 127 funds tracked by Wall St. Rank hold KIDS as of Q1 2022.

  • Prospect Capital Advisors reported no remaining OrthoPediatrics position as of Q1 2022 after selling out during the quarter.
  • Prospect Capital Advisors sold 22,500 OrthoPediatrics shares in Q1 2022, an estimated $1.35M.
  • Prospect Capital Advisors first reported a position in OrthoPediatrics in Q4 2018 and held it in 13 quarters.
  • Prospect Capital Advisors's OrthoPediatrics position peaked at $9.95M in Q3 2019.
  • 127 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2022.

Based on Prospect Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.